Clariane Past Earnings Performance
Past criteria checks 0/6
Clariane's earnings have been declining at an average annual rate of -50.9%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 8.2% per year.
Key information
-50.9%
Earnings growth rate
-98.3%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 8.2% |
| Return on equity | -3.0% |
| Net Margin | -2.5% |
| Next Earnings Update | 24 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Clariane makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 5,170 | -129 | 565 | 0 |
| 31 Mar 24 | 5,083 | -111 | 555 | 0 |
| 31 Dec 23 | 4,996 | -92 | 545 | 0 |
| 30 Sep 23 | 4,865 | -32 | 527 | 0 |
| 30 Jun 23 | 4,735 | 28 | 509 | 0 |
| 31 Mar 23 | 4,587 | 32 | 483 | 0 |
| 31 Dec 22 | 4,438 | 36 | 458 | 0 |
| 30 Jun 22 | 4,288 | 85 | 439 | 0 |
| 31 Mar 22 | 4,212 | 92 | 434 | 0 |
| 31 Dec 21 | 4,137 | 100 | 430 | 0 |
| 30 Sep 21 | 4,047 | 76 | 404 | 0 |
| 30 Jun 21 | 3,941 | 60 | 425 | 0 |
| 31 Mar 21 | 3,857 | 50 | 431 | 0 |
| 31 Dec 20 | 3,773 | 39 | 437 | 0 |
| 30 Sep 20 | 3,728 | 57 | 446 | 0 |
| 30 Jun 20 | 3,683 | 74 | 456 | 0 |
| 31 Mar 20 | 3,648 | 94 | 452 | 0 |
| 31 Dec 19 | 3,613 | 115 | 449 | 0 |
| 30 Sep 19 | 3,542 | 117 | 528 | 0 |
| 30 Jun 19 | 3,471 | 119 | 607 | 0 |
| 31 Mar 19 | 3,404 | 121 | 686 | 0 |
| 31 Dec 18 | 3,336 | 123 | 765 | 0 |
| 30 Sep 18 | 3,280 | 152 | 755 | 0 |
| 30 Jun 18 | 3,224 | 180 | 744 | 0 |
| 31 Mar 18 | 3,177 | 172 | 739 | 0 |
| 31 Dec 17 | 3,131 | 163 | 735 | 0 |
| 30 Sep 17 | 3,091 | 150 | 736 | 0 |
| 30 Jun 17 | 3,052 | 137 | 738 | 0 |
| 31 Mar 17 | 3,017 | 134 | 733 | 0 |
| 31 Dec 16 | 2,981 | 131 | 728 | 0 |
| 30 Sep 16 | 2,880 | 87 | 706 | 0 |
| 30 Jun 16 | 2,779 | 42 | 684 | 0 |
| 31 Mar 16 | 2,676 | 50 | 674 | 0 |
| 31 Dec 15 | 2,573 | 59 | 664 | 0 |
| 30 Sep 15 | 2,553 | 77 | 664 | 0 |
| 30 Jun 15 | 2,533 | 95 | 664 | 0 |
| 31 Mar 15 | 2,378 | 78 | 631 | 0 |
| 31 Dec 14 | 2,222 | 61 | 597 | 0 |
| 30 Sep 14 | 1,938 | 44 | 526 | 0 |
| 30 Jun 14 | 1,654 | 27 | 455 | 0 |
| 31 Mar 14 | 1,505 | 28 | 423 | 0 |
| 31 Dec 13 | 1,356 | 29 | 391 | 0 |
Quality Earnings: 0OPS is currently unprofitable.
Growing Profit Margin: 0OPS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0OPS is unprofitable, and losses have increased over the past 5 years at a rate of 50.9% per year.
Accelerating Growth: Unable to compare 0OPS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0OPS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.6%).
Return on Equity
High ROE: 0OPS has a negative Return on Equity (-2.99%), as it is currently unprofitable.